Teva announces early tender results of its debt tender offer, increase of the maximum tender amount and election of early settlement

Tel aviv, israel--(business wire)--teva pharmaceutical industries ltd. (nyse and tase: teva) (“teva”) announced today the early tender results in connection with its previously announced tender offers (the “offers”) and that it is increasing the combined aggregate purchase price (exclusive of accrued and unpaid interest) (the “total maximum amount”) from $3,500,000,000 to $4,000,000,000 for the following series of notes issued by finance subsidiaries of teva and guaranteed by teva: 1.250% senio
TEVA Ratings Summary
TEVA Quant Ranking